Results 21 to 30 of about 3,972 (210)
Reumatismo, 2023 Psoriatic arthritis (PsA) is an inflammatory disease characterized by peripheral and axial involvement. Biological disease-modifying antirheumatic drugs (bDMARDs) are the mainstream treatment for PsA and bDMARDs retention rate is a proxy for the drug’s ...
G. Adami +8 more
doaj +1 more source
THE SIGNATURE OF INTESTINAL DYSBIOSIS IN INFLAMMATORY RHEUMATIC DISEASES [PDF]
Romanian Journal of Rheumatology, 2019 The study of intestinal microbiota is an important and current subject. It is well known that the gut microbiota plays a decisive role in the development of intestinal function, contributes to the defense against different infections, gives tolerance to ...
Anca Cardoneanu +2 more
doaj +1 more source
Diagnostic delay in axial spondylarthritis: A lost battle? [PDF]
, 2023 Diagnostic delay in axial spondylarthritis (axSpA) remains an unacceptable worldwide problem; with evidence suggesting significant detrimental impact both clinically on the individual, and economically on society.
Karl Gaffney +5 more
core +1 more source
Targeted Therapies in Axial Psoriatic Arthritis
Frontiers in Genetics, 2021 Specific and high-quality evidence on the efficacy of the current targeted therapies for axial disease in psoriatic arthritis (axPsA) is still scarce.
Alberto Floris +5 more
doaj +1 more source
The association of relapsing polychondritis and spondylarthritis – three case reports [PDF]
Romanian Journal of Rheumatology, 2023 Background. Relapsing polychondritis (RP) is characterized by recurrent episodes of progressive inflammation that lead to the destruction of cartilaginous structures.
Eleonora Alina Dragomir-Lica +4 more
doaj +1 more source
Frontiers in Medicine, 2022 ObjectiveTo evaluate the evidence regarding the prevalence and risk of bundle branch block (BBB), atrioventricular block (AVB) and pacemaker implantation (PMI) in patients with spondyloarthritis compared to a control group without spondyloarthritis ...
Hye Sang Park +12 more
doaj +1 more source
Cardiovascular damage in seronegative spondylarthritis
One Health & Risk Management, 2022 Cardiovascular mortality in patients diagnosed with seronegative spondyloarthritis (SSN) is on the rise. Impairment of the cardiovascular system in ankylosing spondylitis (SpA) is 20-40%, in psoriatic arthritis (APs) 18-22% and in reactive arthritis (ARe)
Mihaela STOICA +4 more
doaj +3 more sources
Mini-Review: Human Microbiome and Rheumatic Diseases
Frontiers in Cellular and Infection Microbiology, 2020 Rheumatoid arthritis and spondyloarthropathy are the most common inflammatory rheumatic diseases. As the human microbiome is involved in the immune homeostasis, it has the potential to be a key factor in the development of autoimmune diseases and ...
Meltem Vural +4 more
doaj +1 more source
Histocompatibility HLA class I in anterior uveitis patients with and without spondyloarthritis
Современная ревматология, 2018 Anterior uveitis (AU) and ankylosing spondylitis (AS) are associated with histocompatibility human leukocyte antigen (HLA)-B27. Previous genetic studies conducted in different populations have also demonstrated other genetic associations, including HLA ...
I. A. Guseva +2 more
doaj +1 more source
PULMONARY MANIFESTATIONS DURING SPONDYLARTHRITIS
, 2020 Introduction: Pleuropulmonary involvement in spondylarthritis has long been considered a rare and late manifestation of this group of diseases because of its asymptomatic nature and the failure of chest X-ray to detect early lung injury.
Tarik Youssoufi , Mehdi Boudhar , Fatima Zahra Haddani , Oulahri Soumia , Youssef El. Jebbouri , Abdelhafid Guich and Hasna Hassikou
core +1 more source